GlassScriptPhysician profile
Kiran Reddy
NPI 1134415961
$14,300.37
in general payments reported to CMS, 2019-2025
29 companies · $1,689 in 2025
The $1,689 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $994 · 2021: $1,645 · 2022: $1,165 · 2023: $5,890 · 2024: $1,345 · 2025: $1,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,370 · Consulting Fee: $3,488 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,370.42 |
| Consulting Fee | $3,487.50 |
| Travel and Lodging | $1,065.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,557.77 | 2019-2025 | Avvigo Guidance System, Rotapro, Ekosonic |
| Abiomed | $1,344.45 | 2022-2025 | Impella |
| Inari Medical, INC. | $1,189.22 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ekos Corporation | $1,066.87 | 2019 | |
| Abbott Laboratories | $645.78 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Perclose Proglide, Esprit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $589.02 | 2020-2022 | |
| Medtronic, INC. | $351.30 | 2021-2025 | Symplicity G3 |
| Novo Nordisk INC | $264.20 | 2020-2025 | Rybelsus, Ozempic |
| Penumbra, INC. | $226.52 | 2019-2025 | Indigo System |
| Amgen INC. | $216.58 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $211.08 | 2020-2025 | Farxiga |
| Shockwave Medical, INC | $187.14 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $179.04 | 2019-2025 | |
| Cardiovascular Systems INC. | $167.75 | 2021 | |
| Merck Sharp & Dohme LLC | $144.06 | 2021-2025 | Verquvo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $125.00 | 2019 | |
| Pfizer INC. | $122.18 | 2022-2025 | |
| Stryker Corporation | $117.04 | 2025 | Flowtriever |
| Medtronic Vascular, INC. | $110.10 | 2020 | |
| Cardiva Medical, INC. | $104.03 | 2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $87.96 | 2024-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.18 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $49.13 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $46.61 | 2022 | |
| Esperion Therapeutics, INC. | $40.07 | 2024-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $32.62 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.21 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $21.86 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiran Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.